⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Biotech’s Next Wave May Already be in Motion
globenewswire.com
NTHI
LLY
NVO
REGN
As AI Rewrites Drug Development, the Industry Gathers in Philadelphia to Work Out the Rules
prnewswire.com
PFE
LLY
NVO
AMGN
GOOG
Novo Nordisk's adjusted operating profit reached DKK 32,858 million in Q1 2026
globenewswire.com
NVO
Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
NVO
PFE
CSL
SNY
BMRN
ALNY
SANG
BE
REGN
NTLA
JNJ
ABBV
BMY
TEO
VRTX
CRSP
Hepta Reveals Blood-Based Epigenetic Signatures of GLP-1 Response, Enabling Precision Medicine in Obesity and MASH
businesswire.com
NVO
Ozempic Market to Surpass USD 61.92 Billion by 2035 as GLP-1 Therapies Transform Diabetes and Obesity Care | SNS Insider
globenewswire.com
NVO
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
People & Planet United Summit Brings Together Cross-Sector Voices to Advance Health, AI Innovation, and Global Responsibility
prnewswire.com
MSFT
NVO
Parker Waichman LLP Files Lawsuit on behalf of South Carolina Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic
prnewswire.com
NVO
Refills GLP-1 Weight Loss Claims Evaluated: The Most Affordable Personalized Semaglutide & Tirzepatide GLP1 Program with Online Doctor Support
globenewswire.com
LLY
NVO